Detalhe da pesquisa
1.
Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
Hematol Oncol
; 39(3): 313-325, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942348
2.
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.
BMC Immunol
; 21(1): 39, 2020 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600256
3.
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Mod Pathol
; 25(11): 1473-80, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22684217
4.
First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.
Cochrane Database Syst Rev
; 10: CD004626, 2012 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23076906
5.
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
J Bone Oncol
; 33: 100420, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35340302
6.
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment.
Cancer Med
; 9(14): 4991-5007, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436621
7.
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.
Onkologie
; 31(1-2): 49-51, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18268399
8.
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
Lung Cancer
; 112: 216-224, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916198
9.
Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.
J Clin Oncol
; 23(21): 4669-78, 2005 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16034043
10.
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial.
J Clin Oncol
; 23(28): 7024-31, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16145065
11.
SGN-30 (Seattle genetics).
Curr Opin Mol Ther
; 8(2): 164-72, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16610770
12.
Current treatment and immunotherapy of Hodgkin's lymphoma.
Haematologica
; 90(12): 1680-92, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16330443
13.
A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.
Clin Cancer Res
; 8(6): 1779-86, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060617
14.
ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability.
Oncotarget
; 6(12): 10577-85, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25868855
15.
Monoclonal antibody-based immunotherapy of Hodgkin's lymphoma.
Curr Opin Investig Drugs
; 5(12): 1262-7, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15648946
16.
Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas.
Haematologica
; 88(8): 888-94, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12935976
17.
Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
J Clin Oncol
; 31(35): 4431-7, 2013 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190119
18.
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).
Blood
; 111(1): 109-11, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17938252
19.
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo.
Blood
; 107(5): 1955-62, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16210338
20.
The role of pixantrone in the treatment of non-Hodgkin's lymphoma.
Expert Opin Investig Drugs
; 14(8): 1055-61, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16050797